Cargando...
The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced
BACKGROUND: The global pandemic COVID-19 caused by the new coronavirus SARS-CoV-2 has already caused about 1.4 million deaths, and to date, there are no effective or direct antiviral vaccines. Some vaccines are in the last stages of testing. Overall mortality rates vary between countries, for exampl...
Gardado en:
| Publicado en: | Egypt Liver Journal |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7838235/ https://ncbi.nlm.nih.gov/pubmed/34777865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s43066-021-00082-y |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|